NCT02798107View on ClinicalTrials.gov

Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

May 20, 2019

Primary Completion Date

May 23, 2019

Study Completion Date

May 24, 2019

Conditions
Hemorrhage
Interventions
DRUG

idarucizumab

drug

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02798107 - Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients | Biotech Hunter | Biotech Hunter